{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:26Z","timestamp":1787010146287,"version":"build-2736575974"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:p>An estimated 170 million people worldwide suffer from chronic hepatitis C virus (HCV) infection, which is the main reason for liver transplantation in numerous nations. Traditional Chinese medicine is also frequently employed in medicine to treat HCV. Xiaoyandina is frequently employed in traditional medicine, and which has traditionally been used to cure acute and chronic hepatitis, jaundice, acute and chronic cholecystitis, and acute and chronic cholangitis. The information related to active compounds was retrieved from public databases and through literature review which was later combined with differentially expressed genes obtained through microarray datasets; a compound\u2013target genes\u2013disease network was constructed which uncovered that Kaempferol, Sesamin, and Quercetin decisively contributed to the cell growth and proliferation by affecting STAT1, interleukin-6, and CXCL10 proteins. The molecular docking and molecular dynamics simulation of 50 ns well complemented the binding affinity of the compound and revealed strong stability of predicted compounds at the docked site. In total, compound targets were obtained separately from Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. And 27, 10,894, 6, and 20 disease targets were acquired separately based on OMIM, GeneCard, DrugBank, and PharmGkb databases. Then, we constructed the compound\u2013target network and protein\u2013protein interaction network. Three hundred ninety-four differentially expressed genes were observed (231 up-regulated and 163 downregulated genes). Hub genes were screened through survival analysis, including interleukin-6, STAT1, and CXCL10. Finally, molecular docking and molecular dynamics analysis results showed more stable binding between 3 hub genes and the 2 most active compounds Kaempferol and Quercetin. Our research suggests a novel scientific approach for evaluating the multi-component, multi-target impact of XYDN\u2019s active compounds. The present investigation suggested Quercetin, Kaempferol, and Sesamin as possible HCV treatments by combining bioinformatics techniques and network pharmacology. But the findings were not validated in actual patients, so further investigation is needed to confirm the potential use of XYDN towards HCV.<\/jats:p>","DOI":"10.1097\/md.0000000000041793","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:05:27Z","timestamp":1742310327000},"page":"e41793","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Elucidating the multi-target pharmacological mechanism of Xiaoyandina for the treatment of hepatitis C virus based on bioinformatics and cyberpharmacology studies"],"prefix":"10.1097","volume":"104","author":[{"given":"Dilihuma","family":"Dilimulati","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"},{"name":"Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines, Urumqi, Xinjiang, China"},{"name":"Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, China"},{"name":"Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuerbiye","family":"Nueraihemaiti","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"},{"name":"Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines, Urumqi, Xinjiang, China"},{"name":"Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, China"},{"name":"Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sendaer","family":"Hailati","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"},{"name":"Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines, Urumqi, Xinjiang, China"},{"name":"Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, China"},{"name":"Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"},{"name":"Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines, Urumqi, Xinjiang, China"},{"name":"Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, China"},{"name":"Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayisaier","family":"Abudurousuli","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"},{"name":"Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines, Urumqi, Xinjiang, China"},{"name":"Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, China"},{"name":"Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nulibiya","family":"Maihemuti","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"},{"name":"Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines, Urumqi, Xinjiang, China"},{"name":"Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, China"},{"name":"Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alhar","family":"Baishan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"},{"name":"Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines, Urumqi, Xinjiang, China"},{"name":"Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, China"},{"name":"Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfira","family":"Aikebaier","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"},{"name":"Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines, Urumqi, Xinjiang, China"},{"name":"Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, China"},{"name":"Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maidina","family":"Abulizi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-7634","authenticated-orcid":false,"given":"Wenting","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, P.R. China"},{"name":"Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines, Urumqi, Xinjiang, China"},{"name":"Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, China"},{"name":"Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi, Xinjiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 1","key":"R1-20260108","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/cis361","article-title":"Global burden of hepatitis C: considerations for healthcare providers in the United States.","volume":"55","author":"Averhoff","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"R2-20260108","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/cid\/cis363","article-title":"Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update.","volume":"55","author":"Smith","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R3-20260108","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-2893.2010.01342.x","article-title":"Evidence for separation of HCV subtype 1a into two distinct clades.","volume":"18","author":"Pickett","year":"2011","journal-title":"J Viral Hepat"},{"key":"R4-20260108","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection.","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"R5-20260108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12026-014-8494-3","article-title":"HCV core protein and virus assembly: what we know without structures.","volume":"60","author":"Gawlik","year":"2014","journal-title":"Immunol Res"},{"key":"R6-20260108","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1665-2681(19)30800-2","article-title":"Boceprevir and telaprevir for chronic genotype 1 hepatitis C virus infection. A systematic review and meta-analysis.","volume":"14","author":"Manzano-Robleda","year":"2015","journal-title":"Ann Hepatol"},{"key":"R7-20260108","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJMp1400160","article-title":"Treating hepatitis C in lower-income countries.","volume":"370","author":"Jayasekera","year":"2014","journal-title":"N Engl J Med"},{"key":"R8-20260108","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/v16111739","article-title":"Acute hepatitis C: current status and future perspectives.","volume":"16","author":"Fasano","year":"2024","journal-title":"Viruses"},{"key":"R9-20260108","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2147\/DDDT.S357483","article-title":"Network pharmacology-based strategy combined with molecular docking and in vitro validation study to explore the underlying mechanism of Huo Luo Xiao Ling Dan in treating atherosclerosis.","volume":"16","author":"Sun","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"R10-20260108","doi-asserted-by":"crossref","first-page":"e21825","DOI":"10.1097\/MD.0000000000021825","article-title":"A PRISMA-compliant systematic review and meta-analysis of integrated Chinese and Western medicine in treating hepatitis C.","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R12-20260108","first-page":"11","article-title":"The current situation and prospects of traditional Chinese medicine in the treatment of chronic hepatitis C.","volume":"12","author":"Wang","year":"2008","journal-title":"Chin J Integr Tradit Chin West Med"},{"key":"R13-20260108","first-page":"05","article-title":"Application of Yan Xiao Di Na Er drug combination in the preparation of drugs for the treatment of drug-induced liver injury:CN201510825207.7 [P].","year":"2017"},{"key":"R14-20260108","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.3390\/ijms13066964","article-title":"A novel chemometric method for the prediction of human oral bioavailability.","volume":"13","author":"Xu","year":"2012","journal-title":"Int J Mol Sci"},{"key":"R15-20260108","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0169-409X(02)00003-0","article-title":"Prediction of \u201cdrug-likeness\u201d.","volume":"54","author":"Walters","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"R16-20260108","doi-asserted-by":"crossref","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","article-title":"Expansion of the gene ontology knowledgebase and resources.","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R17-20260108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/nar\/27.1.29","article-title":"KEGG: kyoto encyclopedia of genes and genomes.","volume":"27","author":"Ogata","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"R18-20260108","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R19-20260108","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank.","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"R20-20260108","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility.","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"R21-20260108","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data.","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R22-20260108","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox.","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J Cheminform"},{"key":"R23-20260108","first-page":"495","article-title":"Based on network pharmacology, molecular docking, and molecular dynamics simulation to explore the target mechanism of Rongchang Capsules in the treatment of pediatric epilepsy.","volume":"40","author":"Zimeng","year":"2023","journal-title":"Tianjin J Tradit Chin Med"},{"key":"R24-20260108","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS.","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"R25-20260108","first-page":"65","article-title":"Influence of network topology on critical coupling parameters in synchronization of small world neutral networks.","volume":"11","author":"Li","year":"2009","journal-title":"Far East J Dyn Syst"},{"key":"R26-20260108","doi-asserted-by":"crossref","first-page":"e83922","DOI":"10.1371\/journal.pone.0083922","article-title":"Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology.","volume":"8","author":"Hsin","year":"2013","journal-title":"PLoS One"},{"key":"R27-20260108","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s42535-022-00525-w","article-title":"In-silico docking studies of selected phytochemicals against papain like protease of SARS-CoV-2.","volume":"36","author":"Saranya","year":"2023","journal-title":"Vegetos"},{"key":"R28-20260108","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3748\/wjg.14.7149","article-title":"Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.","volume":"14","author":"Larrubia","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R29-20260108","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/hep.22763","article-title":"Chemokines in the immunopathogenesis of hepatitis C infection.","volume":"49","author":"Heydtmann","year":"2009","journal-title":"Hepatology"},{"key":"R30-20260108","doi-asserted-by":"crossref","first-page":"e34548","DOI":"10.1371\/journal.pone.0034548","article-title":"Treatment of hepatitis C as prevention: a modeling case study in Vietnam.","volume":"7","author":"Durier","year":"2012","journal-title":"PLoS One"},{"key":"R31-20260108","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.3184","article-title":"Global control of hepatitis C: where challenge meets opportunity.","volume":"19","author":"Thomas","year":"2013","journal-title":"Nat Med"},{"key":"R32-20260108","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cid\/ciae485","article-title":"Clinical- and cost-effectiveness of liver disease staging in hepatitis C virus infection: a microsimulation study.","volume":"80","author":"Epstein","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R33-20260108","doi-asserted-by":"crossref","first-page":"107293","DOI":"10.1016\/j.ijid.2024.107293","article-title":"Total burden of hepatitis B and C attributed to injecting drug use in 204 countries and territories from 1990 to 2021: analyses based on the Global Burden of Disease Study 2021.","volume":"150","author":"Huang","year":"2024","journal-title":"Int J Infect Dis"},{"key":"R34-20260108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-med-050223-111239","article-title":"Global elimination of hepatitis C virus.","volume":"76","author":"Fleurence","year":"2025","journal-title":"Annu Rev Med"},{"key":"R35-20260108","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.phymed.2018.09.237","article-title":"Effects of Chinese herbal medicine therapy on survival and hepatic outcomes in patients with hepatitis C virus infection in Taiwan.","volume":"57","author":"Tsai","year":"2019","journal-title":"Phytomedicine"},{"key":"R36-20260108","first-page":"120","article-title":"The current research status of traditional Chinese and Western medicine on hepatitis C.","volume":"10","author":"Li","year":"2022","journal-title":"Chin J Integr Dig Med"},{"key":"R37-20260108","first-page":"41","article-title":"Experimental study on anti-inflammatory and antibacterial effects of Weiyao Yan Xiao Dinar capsules.","volume":"14","author":"Geng","year":"2008","journal-title":"Chin J Ethn Med"},{"key":"R39-20260108","first-page":"329","article-title":"Clinical observation report on the treatment of cholecystitis with Xiaoyandina.","volume":"6","author":"Maiherepu","year":"2002","journal-title":"Chin J Ethnomed Ethnopharm"},{"key":"R40-20260108","first-page":"0007","article-title":"Clinical study on Xiaoyandina.","volume":"6","author":"Abudureheman","year":"2021","journal-title":"CSTJ"},{"key":"R41-20260108","first-page":"61","article-title":"75 cases of chronic cholecystitis treated with Yan Xiao Di Na Er syrup.","volume":"14","author":"Wubulihasimu","year":"2007","journal-title":"Chin J Tradit Chin Med Inf"},{"key":"R42-20260108","first-page":"329","article-title":"Clinical observation report on the treatment of cholecystitis with Wei Yao Yan Xiao Dinar syrup.","volume":"8","author":"Maiherefuti","year":"2002","journal-title":"Chin J Ethn Folk Med"},{"key":"R46-20260108","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.3390\/molecules28145312","article-title":"Phenolic compounds in salicornia spp. and their potential therapeutic effects on H1N1, HBV, HCV, and HIV: a review.","volume":"28","author":"Fredsgaard","year":"2023","journal-title":"Molecules"},{"key":"R47-20260108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/biom11010011","article-title":"Antiviral role of phenolic compounds against dengue virus: a review.","volume":"11","author":"Loaiza-Cano","year":"2020","journal-title":"Biomolecules"},{"key":"R48-20260108","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/molecules22081337","article-title":"A review of the antiviral role of green tea catechins.","volume":"22","author":"Xu","year":"2017","journal-title":"Molecules"},{"key":"R49-20260108","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.3390\/app122110691","article-title":"Pharmacoinformatics analysis reveals flavonoids and diterpenoids from andrographis paniculata and thespesia populnea to target hepatocellular carcinoma induced by hepatitis B virus.","volume":"12","author":"Patil","year":"2022","journal-title":"Appl Sci"},{"key":"R50-20260108","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4254\/wjh.v3.i7.175","article-title":"A Survey on herbal management of hepatocellular carcinoma.","volume":"3","author":"Abdel-Hamid","year":"2011","journal-title":"World J Hepatol"},{"key":"R51-20260108","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.biopha.2016.08.002","article-title":"Therapeutic potential of taraxacum officinale against HCV NS5B polymerase: in-vitro and in silico study.","volume":"83","author":"Rehman","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"R52-20260108","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jhep.2013.06.001","article-title":"Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.","volume":"59","author":"Brownell","year":"2013","journal-title":"J Hepatol"},{"key":"R53-20260108","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.26069","article-title":"Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes.","volume":"57","author":"Sahin","year":"2013","journal-title":"Hepatology"},{"key":"R54-20260108","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/646614","article-title":"Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.","volume":"200","author":"Zeremski","year":"2009","journal-title":"J Infect Dis"},{"key":"R55-20260108","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JVI.80.2.866-874.2006","article-title":"Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6.","volume":"80","author":"Machida","year":"2006","journal-title":"J Virol"},{"key":"R56-20260108","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1084\/jem.20070183","article-title":"Enhanced TLR-mediated NF-IL6\u2013dependent gene expression by Trib1 deficiency.","volume":"204","author":"Yamamoto","year":"2007","journal-title":"J Exp Med"},{"key":"R57-20260108","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/acer.13226","article-title":"Acetaldehyde disrupts interferon alpha signaling in hepatitis C virus-infected liver cells by up-regulating USP18.","volume":"40","author":"Ganesan","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"R58-20260108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2009.03.021","article-title":"Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C.","volume":"47","author":"Joshi-Barve","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"R59-20260108","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1086\/593216","article-title":"Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon.","volume":"198","author":"McCartney","year":"2008","journal-title":"J Infect Dis"},{"key":"R60-20260108","doi-asserted-by":"crossref","first-page":"G566","DOI":"10.1152\/ajpgi.00183.2015","article-title":"Acetaldehyde accelerates HCV-induced impairment of innate immunity by suppressing methylation reactions in liver cells.","volume":"309","author":"Ganesan","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R61-20260108","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.gastro.2003.10.076","article-title":"Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.","volume":"126","author":"Duong","year":"2004","journal-title":"Gastroenterology"},{"key":"R62-20260108","doi-asserted-by":"crossref","first-page":"15342","DOI":"10.1128\/JVI.79.24.15342-15350.2005","article-title":"Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1.","volume":"79","author":"Duong","year":"2005","journal-title":"J Virol"},{"key":"R63-20260108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcmgh.2017.10.004","article-title":"Demethylase JMJD6 as a new regulator of interferon signaling: effects of HCV and ethanol metabolism.","volume":"5","author":"Ganesan","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R64-20260108","doi-asserted-by":"crossref","first-page":"109761","DOI":"10.1016\/j.abb.2023.109761","article-title":"Identification of potential inhibitors against E.coli via novel approaches based on deep learning and quantum mechanics-based atomistic investigations.","volume":"747","author":"Aziz","year":"2023","journal-title":"Arch Biochem Biophys"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:00:55Z","timestamp":1767906055000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041793","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}